These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26920142)

  • 1. Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases.
    Lischalk JW; Malik RM; Collins SP; Collins BT; Matus IA; Anderson ED
    Radiat Oncol; 2016 Feb; 11():28. PubMed ID: 26920142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.
    Lischalk JW; Oermann E; Collins SP; Nair MN; Nayar VV; Bhasin R; Voyadzis JM; Rudra S; Unger K; Collins BT
    Radiat Oncol; 2015 Oct; 10():216. PubMed ID: 26503609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
    Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
    Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules.
    Owen D; Olivier KR; Mayo CS; Miller RC; Nelson K; Bauer H; Brown PD; Park SS; Ma DJ; Garces YI
    Radiat Oncol; 2015 Feb; 10():43. PubMed ID: 25889747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
    Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
    Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
    Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic Stereotactic Body Radiation Therapy in Patients With Recurrent or Metastatic Abdominopelvic Tumors: A Single Institute Experience.
    Sezen D; Gurkaynak M; Gultekin M; Cengiz M; Yildiz F; Zorlu F; Akyol F; Yazici G; Hurmuz P; Ozyigit G
    Technol Cancer Res Treat; 2016 Feb; 15(1):203-11. PubMed ID: 25687510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
    Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
    Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
    Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
    Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.
    Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y
    J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity.
    Testolin A; Favretto MS; Cora S; Cavedon C
    Br J Radiol; 2015; 88(1055):20150228. PubMed ID: 26290398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.
    Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
    Acta Oncol; 2019 Jan; 58(1):74-80. PubMed ID: 30280633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer.
    Hamamoto Y; Kataoka M; Yamashita M; Shinkai T; Kubo Y; Sugawara Y; Inoue T; Sakai S; Aono S; Takahashi T; Semba T; Uwatsu K
    Jpn J Clin Oncol; 2010 Feb; 40(2):125-9. PubMed ID: 19825814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.